Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer
about
Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer
@en
type
label
Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer
@en
prefLabel
Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer
@en
P1476
Phase 1 Study of Combination D ...... tatic EGFR Mutant Lung Cancers
@en
P3098
NCT03810807
P4844
P580
2019-01-17T00:00:00Z
P582
2021-01-01T00:00:00Z